DrugPatentWatch Database Preview
TRANMEP Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Tranmep, and when can generic versions of Tranmep launch?
Tranmep is a drug marketed by Solvay and is included in two NDAs.
The generic ingredient in TRANMEP is meprobamate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for TRANMEP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Bulk Api Vendors: | 28 |
Patent Applications: | 5,055 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRANMEP at DailyMed |

Synonyms for TRANMEP
({2-[(C-hydroxycarbonimidoyloxy)methyl]-2-methylpentyl}oxy)carboximidic acid |
[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate |
[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate |
{2-[(carbamoyloxy)methyl]-2-methylpentyl} carbamate |
063M428 |
1, 2-methyl-2-propyl-, dicarbamate |
1,3-Propanediol, 2-methyl-2-propyl-, 1,3-dicarbamate |
1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate |
1,3-Propanediol,2-methyl-2-propyl-, 1,3-dicarbamate |
2-[(carbamoyloxy)methyl]-2-methylpentyl carbamate |
2-Methyl-2-n-propyl-1,3-propanediol dicarbamate |
2-Methyl-2-propyl-1,3-propanediol dicarbamate |
2-Methyl-2-propyltrimethylene carbamate |
2-Metil-2-n-propil-1,3-propanediol dicarbamato |
2-Metil-2-n-propil-1,3-propanediol dicarbamato [Spanish] |
2,2-Di(carbamoyloxymethyl)pentane |
3P Bamate |
57-53-4 |
9I7LNY769Q |
AC1L1HC1 |
AC1Q2UIX |
AKOS003617983 |
Amepromat |
Amosene |
AN-23587 |
Anastress |
Anathylmon |
Anatimon |
Andaksin |
Andaxin |
Aneural |
Aneurol |
Aneusral |
Aneuxal |
Aneuxral |
Ansiatan |
Ansietan |
Ansil |
Ansiowas |
Anural |
Anxietil |
Anzil |
Apascil |
Apasil |
API0003299 |
Apo-Meprobamate |
Appetrol |
Appetrol-Sr |
Arcoban |
Arpon |
Artolon |
Ataraxine |
Atraxin |
Auxietil |
Ayeramate |
Ayermate |
Bamate |
Bamd 400 |
Bamo 400 |
Biobamat |
Biobamate |
BRN 1788882 |
Brobamate |
C9H18N2O4 |
Calmadin |
Calmax |
Calmiren |
Canquil 400 |
Canquil-400 |
Cap-O-Tran |
Carb-A-Med |
Carbamic acid 2-methyl-2-propyltrimethylene ester |
Carbamic acid, 2-methyl-2-propyltrimethylene ester |
Carbaxin |
CAS-57-53-4 |
CHEBI:6761 |
CHEMBL979 |
Cirpon |
Cirponyl |
component of Appetrol |
component of Appetrol (Salt/Mix) |
component of Deprol (Salt/Mix) |
component of Equalysen |
component of Milpath |
component of Milpath (Salt/Mix) |
component of Milprem |
component of Milprem (Salt/Mix) |
component of Miltrate |
component of Miltrate (Salt/Mix) |
component of PMB-400 |
component of PMB-400 (Salt/Mix) |
Coprobate |
Crestanil |
Cypron |
Cyrpon |
D00376 |
Dapaz |
DB00371 |
DEA No. 2820 |
Deprol |
Despasmol |
Dicandiol |
Diron |
Diurnal |
Diurnaldiverondormabrol |
Diveron |
Dormabrol |
DSSTox_CID_3261 |
DSSTox_GSID_23261 |
DSSTox_RID_76946 |
DTXSID3023261 |
Ecuanil |
Edenal |
EINECS 200-337-5 |
Enorden |
Epicur |
Epikur |
Equagesic |
Equanil |
Equanil (TN) |
Equanil suspension |
Equatrate |
Equazine-M |
Equilium |
Equinil |
Equitar |
Erina |
Estasil |
Fas-Cile |
Fas-Cile 200 |
FT-0653678 |
Gadexyl |
Gagexyl |
GTPL7225 |
Harmonin |
Hartol |
Holbamate |
HSDB 3117 |
I14-2779 |
Ipsotian |
Kesso-Bamate |
Kessobamate |
Klort |
Larten |
Lepenil |
Lepetown |
Letyl |
Libiolan |
LS-120649 |
Mar-Bate |
Margonil |
Mendel |
Mepamtin |
Mepantin |
Mepavlon |
Mepiosine |
Meposed |
Mepr |
Mepranil |
Mepriam |
Meprin |
Meprin (VAN) |
Meprindon |
Mepro-analgesic |
Mepro-Aspirin |
Meprobam |
Meprobamat |
Meprobamat [German] |
Meprobamat-Petrasch |
meprobamate |
Meprobamate (JAN/USP/INN) |
Meprobamate [USAN:INN:BAN:JAN] |
Meprobamate [USP:INN:BAN:JAN] |
Meprobamate 1.0 mg/ml in Methanol |
Meprobamate and Aspirin Tablets |
Meprobamate solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Meprobamate solution, drug standard, 1.0 mg/mL in methanol |
Meprobamate, analytical standard |
Meprobamate, European Pharmacopoeia (EP) Reference Standard |
Meprobamate, United States Pharmacopeia (USP) Reference Standard |
Meprobamato |
Meprobamato [INN-Spanish] |
Meprobamato [Italian] |
Meprobamatum |
Meprobamatum [INN-Latin] |
Meprobamic acid |
Meproban |
Meprocompren |
Meprocon |
Meprocon CMC |
Meprodil |
Meprodiol |
Meprol |
Meproleaf |
Meprosa |
Meprosan |
Meprosin |
Meprospan |
Meprospan-200 |
Meprospan-400 |
Meprotabs |
Meprotan |
Meprotanum |
Meproten |
Meprotil |
Meprovan |
Meprovanmeprozine |
Meprozine |
Meptran |
Meptranactylmilprem |
Metractyl |
Metranquil |
Micrainin |
Microbamat |
Milpath |
Milprem |
Milprem-400 |
Miltamato |
Miltann |
Miltaun |
Miltown |
Miltown (TN) |
Miltown 600 |
Miltrate |
Miltuan |
Miltwon |
Misedant |
MLS003899229 |
Morbam |
Multaun |
My-trans |
NCGC00091031-01 |
NCGC00091031-02 |
NCGC00257886-01 |
Neo-Tran |
Nephentine |
Nervonus |
Neuramate |
NPPQSCRMBWNHMW-UHFFFAOYSA-N |
NSC-30418 |
NSC30418 |
Oasil |
Optarket |
Orlevol |
Orolevol |
Pan-tranquil |
Pancalma |
Panediol |
Pankalma |
Pathibamate |
Pathibamate (Salt/Mix) |
Paxin |
Pensive |
Perequietil |
Perequil |
Perquietil |
Pertranquil |
Pimal |
Placidon |
Placitate |
PMB-200 |
PMB-400 |
Prequil |
Probamato |
Probamyl |
Probate |
Procalmadiol |
Procalmadol |
Procalmidol |
Procarbamide |
Promate |
Promato |
Proquanil |
Protran |
Q-Gesic |
Quaname |
Quanane |
Quanil |
Quietidon |
Quivet |
Rastenil |
Reostral |
Restenil |
Restenyl |
Restinal |
Restinil |
Robamate |
Sadanyl |
SCHEMBL15286 |
Scolazil |
Sedabamate |
Sedanil |
Sedanyl |
Sedazil |
Sedoquil |
Sedoselecta |
Selene |
Seril |
Setran |
Shalvaton |
SK-Bamate |
SMR000058750 |
Solevione anastress |
Sowell |
Spantran |
SR-01000937605 |
SR-01000937605-2 |
Stensolo |
Tamate |
Tensol |
Tensonal |
Tox21_111063 |
Tox21_200332 |
Trancot |
Trankvilan |
Tranlisant |
Tranquilan |
Tranquilate |
Tranquilax |
Tranquiline |
Tranquiline (Intra) |
Tranquilsan |
Tranquinol |
Trelmar |
UNII-9I7LNY769Q |
Urbil |
Urbilat |
Vio-Bamate |
Vistabamate |
W-105461 |
Wardamate |
WLN: ZVO1X3&1&1OVZ |
Wyseals |
ZINC1530701 |
Zirpon |
US Patents and Regulatory Information for TRANMEP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | TRANMEP | meprobamate | TABLET;ORAL | 084369-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Solvay | TRANMEP | meprobamate | TABLET;ORAL | 016249-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |